Group One Trading, L.P. Sangamo Therapeutics, Inc Transaction History

Group One Trading, L.P.

  • $2.2 Billion
  • Q1 2025

A detailed history of Group One Trading, L.P. transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Group One Trading, L.P. holds 289,785 shares of SGMO stock, worth $141,994. This represents 0.01% of its overall portfolio holdings.

Number of Shares
289,785
Previous 202,881 42.83%
Holding current value
$141,994
Previous $206,000 7.28%
% of portfolio
0.01%
Previous 0.01%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
BUY
$0.66 - $1.37 $57,356 - $119,058
86,904 Added 42.83%
289,785 $191,000
Q4 2024

Feb 14, 2025
SELL
$0.78 - $2.87 $140,307 - $516,258
-179,881 Reduced 47.0%
202,881 $206,000
Q3 2024

Nov 14, 2024
BUY
$0.32 - $1.1 $36,584 - $125,758
114,326 Added 42.59%
382,762 $329,000
Q2 2024

Aug 14, 2024
BUY
$0.36 - $0.65 $67,425 - $121,741
187,294 Added 230.82%
268,436 $96,000
Q1 2024

May 10, 2024
SELL
$0.42 - $1.38 $88,336 - $290,249
-210,326 Reduced 72.16%
81,142 $54,000
Q4 2023

Feb 14, 2024
SELL
$0.3 - $0.63 $5,029 - $10,561
-16,765 Reduced 5.44%
291,468 $157,000
Q3 2023

Nov 09, 2023
BUY
$0.58 - $1.47 $110,469 - $279,983
190,465 Added 161.73%
308,233 $184,000
Q2 2023

Aug 09, 2023
SELL
$1.11 - $1.74 $39,046 - $61,207
-35,177 Reduced 23.0%
117,768 $153,000
Q1 2023

May 12, 2023
SELL
$1.66 - $3.67 $31,878 - $70,478
-19,204 Reduced 11.16%
152,945 $269,000
Q4 2022

Feb 09, 2023
SELL
$2.77 - $5.07 $294,556 - $539,133
-106,338 Reduced 38.18%
172,149 $540,000
Q3 2022

Nov 09, 2022
BUY
$4.27 - $6.39 $116,733 - $174,689
27,338 Added 10.89%
278,487 $1.37 Million
Q2 2022

Aug 11, 2022
BUY
$3.28 - $6.21 $87,359 - $165,397
26,634 Added 11.86%
251,149 $1.04 Million
Q1 2022

May 12, 2022
SELL
$5.23 - $7.82 $81,812 - $122,328
-15,643 Reduced 6.51%
224,515 $1.3 Million
Q4 2021

Feb 11, 2022
SELL
$7.29 - $10.97 $46,561 - $70,065
-6,387 Reduced 2.59%
240,158 $1.8 Million
Q3 2021

Nov 12, 2021
BUY
$9.01 - $12.01 $689,301 - $918,813
76,504 Added 44.99%
246,545 $2.22 Million
Q2 2021

Aug 10, 2021
SELL
$10.17 - $12.64 $1.01 Million - $1.26 Million
-99,321 Reduced 36.87%
170,041 $2.04 Million
Q1 2021

May 12, 2021
SELL
$10.88 - $17.05 $100,988 - $158,258
-9,282 Reduced 3.33%
269,362 $3.38 Million
Q4 2020

Feb 10, 2021
BUY
$9.23 - $18.18 $1.51 Million - $2.98 Million
163,875 Added 142.79%
278,644 $4.35 Million
Q3 2020

Nov 12, 2020
SELL
$9.38 - $12.48 $326,377 - $434,241
-34,795 Reduced 23.26%
114,769 $1.09 Million
Q2 2020

Aug 13, 2020
BUY
$6.21 - $11.83 $20,461 - $38,979
3,295 Added 2.25%
149,564 $1.34 Million
Q1 2020

May 13, 2020
BUY
$5.05 - $8.85 $99,990 - $175,230
19,800 Added 15.66%
146,269 $932,000
Q4 2019

Feb 10, 2020
BUY
$8.03 - $11.7 $312,607 - $455,481
38,930 Added 44.47%
126,469 $1.06 Million
Q3 2019

Nov 12, 2019
BUY
$9.05 - $12.22 $236,693 - $319,601
26,154 Added 42.61%
87,539 $792,000
Q2 2019

Aug 09, 2019
BUY
$8.75 - $13.03 $468,282 - $697,339
53,518 Added 680.28%
61,385 $661,000
Q1 2019

May 13, 2019
BUY
$7.72 - $12.81 $60,733 - $100,776
7,867 New
7,867 $75,000
Q4 2018

Feb 06, 2019
SELL
$9.51 - $16.6 $1.49 Million - $2.6 Million
-156,777 Closed
0 $0
Q3 2018

Nov 08, 2018
BUY
$13.05 - $19.05 $903,999 - $1.32 Million
69,272 Added 79.16%
156,777 $2.66 Million
Q2 2018

Aug 14, 2018
BUY
$13.9 - $19.8 $34,777 - $49,539
2,502 Added 2.94%
87,505 $1.24 Million
Q1 2018

May 11, 2018
SELL
$16.7 - $26.35 $2.62 Million - $4.13 Million
-156,726 Reduced 64.84%
85,003 $1.62 Million
Q4 2017

Feb 09, 2018
BUY
$11.6 - $17.35 $261,835 - $391,624
22,572 Added 10.3%
241,729 $3.96 Million
Q3 2017

Nov 15, 2017
SELL
$8.4 - $15.0 $141,128 - $252,015
-16,801 Reduced 7.12%
219,157 $3.29 Million
Q2 2017

Aug 14, 2017
BUY
N/A
235,958
235,958 $2.08 Million

Others Institutions Holding SGMO

# of Institutions
137
Shares Held
51.2M
Call Options Held
2.17M
Put Options Held
1.82M
View Full List

About SANGAMO THERAPEUTICS, INC

SGMO Quotes by TradingView
  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $76.7M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email